| Net Cash Provided by (Used in) Operating Activities |
-18.5K |
USD |
+4.13% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
18.5K |
USD |
-4.13% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
10B |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
760M |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
|
Q3 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
183K |
USD |
+8.01% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
183K |
USD |
+8.01% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
869K |
USD |
+8.01% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |